Bariatric Surgery versus Conventional Medical Therapy for Type 2 Diabetes
For a few, the results didnt go far enough
only GLP-1 agonist with dedicated cardiovascular outcomes data in obesity population Maximizing weight loss beyond GLP-1 monotherapy Survodutide Phase 2 data suggest up to 19% weight loss
To date, however, no studies have specifically assessed this endpoint in migraine populations, highlighting a critical gap in the literature and an opportunity for future clinical trials
Plus, mounting evidence supports their use for safe and effective immune support through their influence on improved barrier function, NK cell activity, and B-cell and T-cell maturation and differentiation
Includes fluid therapy for dehydration, a powerful anti-nausea medication and anti-inflammatory to help with muscle and joint aches